Abstract: Systems and methods including one or more processors and one or more non-transitory storage devices storing computing instructions configured to run on the one or more processors and perform acts of receiving a unique identifier from a user, wherein the unique identifier is associated with a purchase of a physical media item; determining when the unique identifier is associated with an electronic media account; when the unique identifier is associated with the electronic media account: sending a verification message to an electronic communication address associated with the unique identifier to (a) inform the user of an availability of electronic media associated with the physical media item and (b) provide a verification token that, when transmitted to an electronic media provider, facilitates a modification of the electronic media account to grant access to the electronic media associated with the physical media item; and when the unique identifier is not associated with the electronic media account: storin

Abstract: Polymeric adsorbents useful for solid phase extraction (SPE) comprising a copolymer formed by copolymerizing at least one hydrophobic monomer including divinylbenzene and at least one hydrophilic monomer including acrylonitrile are provided. Also provided are SPE cartridges including a divinylbenzene-acrylonitrile hydrophilic-lipophilic balance adsorbent. Further provided are methods of using a divinylbenzene-acrylonitrile hydrophilic-lipophilic balance adsorbent in conventional and simplified SPE techniques.

Abstract: A composition, method and device for the preparation of biological samples for subsequent LC-MS analysis using a combined and concurrent protein precipitation and solid phase extraction (SPE) process is described. Through an integrated combination of protein precipitation, filtration, and SPE using a novel zirconia-coated chromatographic media, interfering compounds, such as proteins and phosphate-containing compounds, are eliminated from the biological samples, affording a higher degree of analyte response during LC-MS analysis.

Abstract: Polymeric adsorbents useful for solid phase extraction (SPE) comprising a copolymer formed by copolymerizing at least one hydrophobic monomer including divinylbenzene and at least one hydrophilic monomer including acrylonitrile. Also provided are SPE cartridges including a divinylbenzene-acrylonitrile hydrophilic-lipophilic balance adsorbent. Further provides are methods of using a divinylbenzene-acrylonitrile hydrophilic-lipophilic balance adsorbent in conventional and simplified SPE techniques.

Abstract: Systems and methods including one or more processors and one or more non-transitory storage devices storing computing instructions configured to run on the one or more processors and perform acts of receiving a unique identifier from a user, wherein the unique identifier is associated with a purchase of a physical media item; determining when the unique identifier is associated with an electronic media account; when the unique identifier is associated with the electronic media account: sending a verification message to an electronic communication address associated with the unique identifier to (a) inform the user of an availability of electronic media associated with the physical media item and (b) provide a verification token that, when transmitted to an electronic media provider, facilitates a modification of the electronic media account to grant access to the electronic media associated with the physical media item; and when the unique identifier is not associated with the electronic media account: storin

Abstract: A system and method for giving access to streaming media that is associated with purchased physical media item is disclosed herein. Upon the purchase of a physical media item, a unique identifier is received. The unique identifier is analyzed to determine if the unique identifier is associated with a streaming service account. If so, the streaming service account is modified to grant access to streaming media that is associated with the physical media. The user is notified of the availability of the streaming media. The user can then initiate playback of the streaming media. Other embodiments are also disclosed herein.

Abstract: A multi-book accounting system capable of immediately updating all secondary books regardless of underlying currency when transactions are entered in the primary book with respect to consolidation and elimination aspects. This may be accomplished by using a consolidated exchange rate database that can serve as a basis for currency exchange rates for any book in a multi-book setting. Thus, users will be able to run consolidated reports via a multi-tenant online accounting service. Consolidated impact of any transaction will be calculated automatically when any consolidated report in any secondary book is invoked similar to the process with respect to any primary book. A separate set of consolidated exchange rates may be applied in the various secondary accounting books. Furthermore, users will be able to run automatic intercompany elimination via a multi-tenant online accounting service for secondary books in the same way as it is possible for primary accounting book.

Abstract: A system and method for giving access to streaming media that is associated with purchased physical media item is disclosed herein. Upon the purchase of a physical media item, a unique identifier is received. The unique identifier is analyzed to determine if the unique identifier is associated with a streaming service account. If so, the streaming service account is modified to grant access to streaming media that is associated with the physical media. The user is notified of the availability of the streaming media. The user can then initiate playback of the streaming media. Other embodiments are also disclosed herein.

Abstract: The present invention provides compounds having a structure according to Formula (I): or a salt or solvate thereof, wherein ring A, E1, E2, R1, R2, R3 and R4 are defined herein. The invention further provides pharmaceutical compositions including the compounds of the invention and methods of making and using the compounds and compositions of the invention, e.g., in the treatment and prevention of various disorders, such as Parkinson's disease.

Abstract: A mounting assembly (1) for a solar panel, comprising beams (10), pressing blocks (30) and a plurality of anti-slip blocks (40), said beams (10) are paralleled and transversely fixed to installation part outdoors, and the upper portion of said beam (10) is provided with a long groove (101) along the longitudinal direction of the beam, and the opposing side walls of said long groove (101) extended to said groove (101) to form a supporting portion (102), one end of said anti-slip block (30) is slidably inserted into said long groove (101), the other end of said anti-slip block (30) is loaded on said supporting portion (102) and is fixed to the back of said solar panel, and said pressing block (20) is pushed and pressed on the side edge of said solar panel and is fixed to said beam (10).

Abstract: A method to facilitate a failure modes and effects analysis (FMEA) project associated with one or more components or process during a product development cycle is provided. The method includes displaying on the user interface one or more information pages associated with sequential order of elements to be completed by one or more FMEA analysts. The method further involves receiving with an aid of the user interface textual inputs from the one or more FMEA analysts for the one or more information pages associated with the sequential orders of elements. The method further includes developing a risk chart for tracking a risk mitigation progress for the FMEA project associated with the one or more components or process during the product development cycle. The risk charts include a Criticality Matrix Risk Chart (CMRC) and a Pro-active Reliability Risk Chart (PRRC).

Abstract: A method to facilitate a failure modes and effects analysis (FMEA) project associated with one or more components or process during a product development cycle is provided. A real time FMEA status is viewable through a user interface which indicates the progress of the FMEA project. The method includes displaying on the user interface one or more information pages associated with sequential order of elements to be completed by one or more FMEA analysts. The method further involves receiving with an aid of the user interface textual inputs from the one or more FMEA analysts for the one or more information pages associated with the sequential orders of elements. The method further includes representing, to the one or more FMEA analysts, the sequential order of elements in a tree structure format. The information associated with the sequential order of elements is editable and is updated in real time.

Abstract: Disclosed are sulfonylquinoxalone acetamide derivatives useful as bradykinin antagonists.

Abstract: A composition, method and device for the preparation of biological samples for subsequent LC-MS analysis using a combined and concurrent protein precipitation and solid phase extraction (SPE) process is described. Through an integrated combination of protein precipitation, filtration, and SPE using a novel zirconia-coated chromatographic media, interfering compounds, such as proteins and phosphate-containing compounds, are eliminated from the biological samples, affording a higher degree of analyte response during LC-MS analysis.

Abstract: Disclosed are sulfonylquinoxalone derivatives of the general formula: These compounds are useful as bradykinin antagonists.

Abstract: Disclosed are sulfonylquinoxalone acetamide derivatives useful as bradykinin antagonists.

Abstract: Disclosed are 1-sulfonylquioxalone acetamides and derivatives thereof. The compounds are exemplified by compounds of the formula: Such compounds, derivatives and related compounds are useful as bradykinin antagonists.

Abstract: Disclosed are sulfonylquinoxalone acetamide derivatives useful as bradykinin antagonists.

Abstract: Disclosed are sulfonylquinoxalone acetamide derivatives useful as bradykinin antagonists.